Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.

Hassan AO, Amen O, Sayedahmed EE, Vemula SV, Amoah S, York I, Gangappa S, Sambhara S, Mittal SK.

PLoS One. 2017 Oct 12;12(10):e0186244. doi: 10.1371/journal.pone.0186244. eCollection 2017.

2.

Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.

Lee CS, Bishop ES, Zhang R, Yu X, Farina EM, Yan S, Zhao C, Zheng Z, Shu Y, Wu X, Lei J, Li Y, Zhang W, Yang C, Wu K, Wu Y, Ho S, Athiviraham A, Lee MJ, Wolf JM, Reid RR, He TC.

Genes Dis. 2017 Jun;4(2):43-63. doi: 10.1016/j.gendis.2017.04.001. Epub 2017 Apr 27.

3.

Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin.

Peng B, Peng N, Zhang Y, Zhang F, Li X, Chang H, Fang F, Wang F, Lu F, Chen Z.

Front Immunol. 2017 Aug 31;8:1070. doi: 10.3389/fimmu.2017.01070. eCollection 2017.

4.

A modified vaccinia Ankara vaccine vector expressing a mosaic H5 hemagglutinin reduces viral shedding in rhesus macaques.

Florek NW, Kamlangdee A, Mutschler JP, Kingstad-Bakke B, Schultz-Darken N, Broman KW, Osorio JE, Friedrich TC.

PLoS One. 2017 Aug 3;12(8):e0181738. doi: 10.1371/journal.pone.0181738. eCollection 2017.

5.

Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model.

Duehr J, Wohlbold TJ, Oestereich L, Chromikova V, Amanat F, Rajendran M, Gomez-Medina S, Mena I, tenOever BR, García-Sastre A, Basler CF, Munoz-Fontela C, Krammer F.

J Virol. 2017 Jul 27;91(16). pii: e00652-17. doi: 10.1128/JVI.00652-17. Print 2017 Aug 15.

PMID:
28592526
6.
7.

A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.

Jiang W, Wang S, Chen H, Ren H, Huang X, Wang G, Chen Z, Chen L, Chen Z, Zhou P.

J Virol. 2017 Apr 13;91(9). pii: e02052-16. doi: 10.1128/JVI.02052-16. Print 2017 May 1.

8.

Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques.

Bolton DL, Song K, Tomaras GD, Rao S, Roederer M.

Vaccine. 2017 Jan 23;35(4):639-646. doi: 10.1016/j.vaccine.2016.12.008. Epub 2016 Dec 29.

PMID:
28041780
9.

Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched Vaccines.

Subramanian R, Graham AL, Grenfell BT, Arinaminpathy N.

PLoS Comput Biol. 2016 Dec 15;12(12):e1005204. doi: 10.1371/journal.pcbi.1005204. eCollection 2016 Dec.

10.

Reconstituted B cell receptor signaling reveals carbohydrate-dependent mode of activation.

Villar RF, Patel J, Weaver GC, Kanekiyo M, Wheatley AK, Yassine HM, Costello CE, Chandler KB, McTamney PM, Nabel GJ, McDermott AB, Mascola JR, Carr SA, Lingwood D.

Sci Rep. 2016 Oct 31;6:36298. doi: 10.1038/srep36298.

11.

Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody.

Shanker S, Czakó R, Sapparapu G, Alvarado G, Viskovska M, Sankaran B, Atmar RL, Crowe JE Jr, Estes MK, Prasad BV.

Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):E5830-E5837. Epub 2016 Sep 19.

12.

Viral vector-based influenza vaccines.

de Vries RD, Rimmelzwaan GF.

Hum Vaccin Immunother. 2016 Nov;12(11):2881-2901. Epub 2016 Jul 25. Review.

13.

Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.

Liu WC, Jan JT, Huang YJ, Chen TH, Wu SC.

J Virol. 2016 Sep 12;90(19):8496-508. doi: 10.1128/JVI.00880-16. Print 2016 Oct 1.

14.

A Fusion Protein Based on the Second Subunit of Hemagglutinin of Influenza A/H2N2 Viruses Provides Cross Immunity.

Stepanova LA, Sergeeva MV, Shuklina MA, Shaldzhyan AA, Potapchuk MV, Korotkov AV, Tsybalova LM.

Acta Naturae. 2016 Apr-Jun;8(2):116-26.

15.

Multi-epitope Models Explain How Pre-existing Antibodies Affect the Generation of Broadly Protective Responses to Influenza.

Zarnitsyna VI, Lavine J, Ellebedy A, Ahmed R, Antia R.

PLoS Pathog. 2016 Jun 23;12(6):e1005692. doi: 10.1371/journal.ppat.1005692. eCollection 2016 Jun.

16.

Baculovirus Displaying Hemagglutinin Elicits Broad Cross-Protection against Influenza in Mice.

Sim SH, Kim JY, Seong BL, Nguyen HH, Chang J.

PLoS One. 2016 Mar 29;11(3):e0152485. doi: 10.1371/journal.pone.0152485. eCollection 2016.

17.

Stalking influenza by vaccination with pre-fusion headless HA mini-stem.

Valkenburg SA, Mallajosyula VV, Li OT, Chin AW, Carnell G, Temperton N, Varadarajan R, Poon LL.

Sci Rep. 2016 Mar 7;6:22666. doi: 10.1038/srep22666.

18.

Novel universal influenza virus vaccine approaches.

Krammer F.

Curr Opin Virol. 2016 Apr;17:95-103. doi: 10.1016/j.coviro.2016.02.002. Epub 2016 Feb 27. Review.

19.

Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses.

Kapczynski DR, Tumpey TM, Hidajat R, Zsak A, Chrzastek K, Tretyakova I, Pushko P.

Vaccine. 2016 Mar 18;34(13):1575-1581. doi: 10.1016/j.vaccine.2016.02.011. Epub 2016 Feb 8.

20.

Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans.

Nachbagauer R, Choi A, Izikson R, Cox MM, Palese P, Krammer F.

MBio. 2016 Jan 19;7(1):e01996-15. doi: 10.1128/mBio.01996-15.

Supplemental Content

Support Center